Browse > Article
http://dx.doi.org/10.15324/kjcls.2018.50.3.261

Estimation of HCV Test in Diagnosis for Chronic Hepatitis C Virus  

Jang, Soon-Mo (Department of Medical Laboratory Science, Jinju Health College)
Yang, Byoung Seon (Department of Medical Laboratory Science, Jinju Health College)
Publication Information
Korean Journal of Clinical Laboratory Science / v.50, no.3, 2018 , pp. 261-266 More about this Journal
Abstract
To determine the clinical utility of an immunoblot test and RT-PCR-hybridization test, 160 samples from patients with a chronic HCV infection were analyzed by two tests. A total of 133 samples out of 150 positive samples were positive by RT-PCR-hybridization. The true positive rate of the immunoblot tests and the concordance rate of the two tests was 88.6% and 89.3%, respectively. Serotyping and genotyping were performed to evaluate the distribution of the HCV subtype in Korean isolates. HCV serotypes 1 and 2, and genotypes 1b and 2a were the most common sources of HCV infections in this group. In 49 cases studied with the serotypes and genotypes, serotypes 1 and 2 were 57.1% and 42.9%, respectively. Genotypes 1b, 1b/2b, 2a, 2a/2c, and 2b were 51.0%, 2.0%, 34.7%, 8.2%, and 4.1%, respectively. This study shows that immunoblot tests are more useful for screening HCV infections. The RT-PCR-hybridization test confirmed the HCV infection in patients with positive immunoblot test results. The serotype test is preferred over the genotype test for monitoring the progression or response to treatment. On the other hand, there were no significant differences in the response to an ${\alpha}$-interferon treatment of HCV infection with serotype type 1 or type 2 in Korea.
Keywords
Hepatitis C virus; Immunoblot; RT-PCR-hybridization;
Citations & Related Records
연도 인용수 순위
  • Reference
1 KCDC. Guidelines for viral Hepatitic C prevention and control [Internet]. Cheonwon: Korea centers for disease control and prevention; 2016 [cited 2018 July 6]. Available from: http://www.cdc.go.kr/CDC/main.jsp.
2 Choo QL, Weiner AJ, Overby LR, Kuo G, Houghton M, Bradley DW. Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis. Br med Bull. 1990;46:423-441.   DOI
3 Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989;244: 359-362.   DOI
4 Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 1989;244: 362-364.   DOI
5 Tanaka E, Kiyosawa K, Nakatsuji Y, Inoue Y, Miyamura T, Chiba J, et al. Clinical significance of antibodies to nonstructural and core proteins of hepatitis C virus in post transfusion hepatitis patients during long-term follow-up. J med Virol. 1993;39:318-324.   DOI
6 Zeuzem S, Ruster B, Roth WK. Clinical evaluation of a new polymerase chain reaction assay (Amplicor HCV) for detection of hepatitis C virus. J Gasteroenterol. 1994;32:342-347.
7 Inchauspe G, Zebedee S, Lee DH, Sugitani M, Nasoff M, Prince AM. Genomic structure of the human protype strain H of hepatitis C virus: comparison with American and Japanese isolates. Proc Natl Acad Sci. 1991;88:10292-10296.   DOI
8 Mita E, Hayashi N, Hagiwara H, Ueda K, Kanazawa Y, Kasahara A, Fusamoto H, et al. Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer. Dig Dis Sci. 1994;39:977-982.   DOI
9 McOmish F, Yap PL, Dow BC, Follett EA, Seed C, Keller AJ, et al. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol. 1994;32:884-892.
10 Okamoto H, Okada S, Sugiyama Y, Kurai K, Iizuka H, Machida A, et al. Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions. J Gen Virol. 1991;72:2679-2704.   DOI
11 Yoshioka K, Kakumu S. Predicting factors for the response to interferon therapy against hepatitis C virus infection: HCV genotyping. Rinsho Byori. 1994;42:1010-1014.
12 Verbaan H, Widell A, Lindgren S, Lindmark B, Nordenfelt E, Eriksson S. Hepatitis C in chronic liver disease: an epidemiological study based on 566 consecutive patients undergoing liver biopsy during a 10-year period. J Int Med. 1992;232:33-42.   DOI
13 Simmonds P, Zhang LQ, Watson HG, Rebus S, Ferguson ED, Balfe P, et al. Hepatitis C quantification and sequencing in blood products, haemophiliacs, and drug users. Lancet. 1990;336:1469-1472.   DOI
14 van der Poel CL, Reesink HW, Schaasberg W, Leentvaar-Kuypers A, Bakker E, Exel-Oehlers PJ, et al. Infective of blood seropositive for hepatitis C virus antibodies. Lancet. 1990; 335:558-560.   DOI
15 Seong MH, Kil H, Kim YS, Bae SH, Lee YJ, Lee HC, Kang BH, Jeong SH. Clinical and epidemiological features of hepatitis C virus infection in South Korea: a prospective, multicenter cohort study. J Med Virol. 2013;85:1724-1733.   DOI